Targeting DRD2 and ClpP in High Grade Glioma with ONC201: Emerging Clinical Results and Future Trials

Time: 12:45 pm
day: Day Two

Details:

  • Review DRD2 as therapeutic target in oncology
  • Update on the latest ONC201 clinical results in H3 K27M-mutant gliomas
  • Overview of ONC201 in other CNS tumors and emerging trials

Speakers: